Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Rahul Banerjee, MD

Photo of Rahul Banerjee, MD
Title(s)Volunteer Clinical Instructor, Medicine
SchoolSchool of Medicine
AddressFlexible, #001
Varies
ORCID ORCID Icon0000-0003-3781-5441 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Alpert Medical School of Brown University, Providence, RIMD05/2014(Medical School)
    Hospital of the University of Pennsylvania, Philadelphia, PAResidency06/2017Internal Medicine
    Philadelphia VA Medical Center, Philadelphia, PAChief Residency06/2018Quality Improvement
    UCSF, San Francisco, CAFellowship06/2021Hematology & Oncology
    UCSF, San Francisco, CAAdvanced Fellowship06/2022BMT/CAR-T Therapy
    Collapse awards and honors
    American Society of Clinical Oncology2019ASCO/AACR Methods in Clinical Cancer Research Workshop (Vail, CO)
    American Society for Transplantation and Cellular Therapy2019ASTCT Clinical Research Training Course (Park City, UT)
    University of California San Francisco2019  - 2020Chief Fellow, Division of Hematology/Oncology
    Warren Alpert Medical School (Brown University)2014Alpha Omega Alpha Honor Medical Society
    Warren Alpert Medical School (Brown University)2014Gold Humanism Honor Society
    American College of PhysiciansElectee, Fellow of the American College of Physicians (FACP)

    Collapse Overview 

    Collapse Research 
    Collapse research activities and funding
    Efficacy of digital life coaching to lower benzodiazepine usage and improve quality of life in multiple myeloma patients undergoing transplantation
    ASCO Conquer Cancer Foundation Young Investigator AwardJul 1, 2020 - Dec 31, 2021
    Role: Principal Investigator
    Description: The goal of this study is to assess whether digital access to a trained life coach via phone calls and text messages can improve patient-reported outcomes during stem cell transplantation.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels. Blood Adv. 2025 Sep 23; 9(18):4720-4726. Banerjee R, Mohan M, Rejeski K, Puliafito BR, Cirstea DD, Kaur G, Midha S, McCaughan GJ, Kumar NM, Mehra N, Bagal B, Raje NS. PMID: 40690761; PMCID: PMC12466225.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Avoid burning bridges before CAR-T therapy in myeloma. Blood Adv. 2025 Aug 26; 9(16):4232-4234. Reddi S, Banerjee R. PMID: 40815506; PMCID: PMC12372939.
      View in: PubMed   Mentions:    Fields:    
    3. Step Count, Step Aside: Newer Physical Activity Metrics to Predict Survival in Oncology. JCO Clin Cancer Inform. 2025 Aug; 9:e2500197. Paturi S, Banerjee R. PMID: 40795197.
      View in: PubMed   Mentions:    Fields:    
    4. Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium. Blood Cancer Discov. 2025 Aug 08; OF1-OF11. Razzo BM, Midha S, Portuguese AJ, Grajales-Cruz AF, De Menezes Silva Corraes A, Costello P, Liu Y, Sperling AS, Nadeem O, Dima D, Banerjee R, Cowan AJ, Afrough A, Anderson LD, Lieberman-Cribbin A, Kaur G, Goyal A, Atrash S, Ferreri CJ, Voorhees PM, Pasvolsky O, Lee HC, Patel KK, Julian KL, Forsberg PA, Herr MM, Chhabra S, Parrondo RD, Lin Y, Chen A, Susanibar-Adaniya SP, Khouri J, Raza S, Anwer F, Vazquez-Martinez M, Castaneda Puglianini O, Sborov DW, Davis JA, Rossi A, Shune L, Bhurtel J, Hwang WT, Hansen DK, Sidana S, Garfall AL, Richard S. PMID: 40778675.
      View in: PubMed   Mentions:    Fields:    
    5. Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy. Blood. 2025 Aug 01. Dhakal B, Akhtar OS, Fandrei D, Jensen A, Banerjee R, Pan D, Richard S, Friend R, Rees MJ, Costello P, Vazquez Martinez MA, Pasvolsky O, Wagner CB, Davis JA, Castaneda Puglianini OA, Reshef R, Afrough A, Dima D, Bhutani M, Nadeem O, Parrondo RD, Freeman CL, Mikkilineni L, Raza S, Anderson LD, Kapoor P, Hosoya H, Chhabra S, Grajales-Cruz A, Gaballa MR, Midha S, Alsina M, Sborov DW, Patel KK, Lin Y, Ferreri CJ, Gagelmann N, Kumar AD, Hansen DK, Cowan AJ, Costa LJ, Merz M, Sidana S. PMID: 40749169.
      View in: PubMed   Mentions: 1     Fields:    
    6. A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma. Front Oncol. 2025; 15:1630146. Garfall AL, Banerjee R, Frenzel L, Khandanpour C, Lin Y, Ottoni E, Rifkin R, Rockwell S, Rodriguez C, Villefort H, Zamagni E. PMID: 40809030; PMCID: PMC12343214.
      View in: PubMed   Mentions:
    7. Assessing Social Determinants of Health in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT. Transplant Cell Ther. 2025 Jul 23. Espinoza-Gutarra MR, Collins J, Kennedy V, Randall J, Su CT, Banerjee R, Wuliji N, Odstricil-Bobillo S, Amonoo HL, Wood WA, Hamilton B, Sung A, Lee CJ. PMID: 40712781; PMCID: PMC12411015.
      View in: PubMed   Mentions:    Fields:    
    8. Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment. Blood Adv. 2025 Jul 22; 9(14):3408-3417. Dima D, Afrough A, Goel U, Grajales-Cruz AF, Khouri J, Julian K, Pasvolsky O, Banerjee R, Razzo B, Ferreri CJ, Vazquez-Martinez MA, Davis JA, Sannareddy A, Castaneda O, Raza S, Portuguese AJ, Gaballa MR, Rana MS, Lieberman-Cribbin A, DeJarnette S, Gonzalez R, Chen A, Herr MM, Mikkilineni L, Hosoya H, Ouchveridze E, Kaur G, Rossi A, Shune L, Anwer F, Lin Y, Richard S, Sborov DW, Baz RC, Garfall AL, Lee HC, Anderson LD, Cowan AJ, Patel KK, Voorhees PM, Sidana S, Hansen DK, Atrash S, Susanibar-Adaniya SP. PMID: 40198766; PMCID: PMC12274829.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Discov. 2025 07 09. Razzo BM, Midha S, Portuguese AJ, Grajales-Cruz AF, De Menezes Silva Corraes A, Costello P, Liu Y, Sperling AS, Nadeem O, Dima D, Banerjee R, Cowan AJ, Afrough A, Anderson LD, Lieberman-Cribbin A, Kaur G, Goyal A, Atrash S, Ferreri CJ, Voorhees PM, Pasvolsky O, Lee HC, Patel KK, Julian KL, Forsberg PA, Herr MM, Chhabra S, Parrondo RD, Lin Y, Chen A, Susanibar-Adaniya SP, Khouri J, Raza S, Anwer F, Vazquez-Martinez M, Castaneda Puglianini O, Sborov DW, Davis JA, Rossi A, Shune L, Bhurtel J, Hwang WT, Hansen DK, Sidana S, Garfall AL, Richard S. PMID: 40629516.
      View in: PubMed   Mentions:    Fields:    
    10. Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT. Transplant Cell Ther. 2025 Jul 01. Banerjee R, Amonoo HL, Barata A, Bhatt NS, Espinoza-Gutarra MR, Jayani-Kosarzycki RV, Katz H, Kennedy VE, Nawas M, Steineck A, Wanjiku C, Costanzo E, Cusatis RN, Knight JM, Schoemans H, Sidana S, Wood WA, Sung AD, Lee CJ, Hamilton BK. PMID: 40609744; PMCID: PMC12243979.
      View in: PubMed   Mentions:    Fields:    
    11. Managing IEC-associated enterocolitis following CAR-T therapy in multiple myeloma. Blood Cancer J. 2025 Jun 30; 15(1):112. Banerjee R, Hosoya H, Mikkilineni L, Hansen DK, Wolf JL, Lin Y. PMID: 40588476; PMCID: PMC12209438.
      View in: PubMed   Mentions:    Fields:    
    12. Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium. Blood Cancer J. 2025 Jun 25; 15(1):111. Dima D, Vazquez-Martinez MA, Davis JA, Goel U, Afrough A, Sannareddy A, Pasvolsky O, Razzo B, Banerjee R, Khouri J, Grajales-Cruz A, Lieberman-Cribbin A, Rana MS, Julian K, DeJarnette S, Portuguese AJ, Gaballa MR, De Avila G, Susaniba Adaniya S, Raza S, Herr MM, Ouchveridze E, Richards T, Hosoya H, Mikkilineni L, Kaur G, Castaneda Puglianini O, Rossi A, Lin Y, Atrash S, Sborov D, Shain KH, Voorhees PM, Richard S, Garfall AL, Hansen DK, Sidana S, Patel KK, Cowan AJ, Anderson LD, Lee HC, Anwer F, Ferreri CJ, Shune L. PMID: 40562770; PMCID: PMC12198414.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Double trouble: Non-relapse mortality with bispecific antibodies in lymphoma and myeloma. Mol Ther. 2025 Jul 02; 33(7):2966-2967. Banerjee R, Yamshon S. PMID: 40562030; PMCID: PMC12266010.
      View in: PubMed   Mentions:    Fields:    
    14. Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma. Haematologica. 2025 Jun 19. Portuguese AJ, Liang EC, Huang JJ, Jeon Y, Dima D, Banerjee R, Kwok M, Cicero KI, Hirayama AV, Basom R, Khouderchah C, Shadman M, Fong L, Cowan AJ, Gauthier J. PMID: 40534492.
      View in: PubMed   Mentions:    Fields:    
    15. Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group. Blood Cancer J. 2025 Jun 18; 15(1):86. Lu X, Andersen EF, Banerjee R, Eno CC, Gonzales PR, Kumar S, Lager AM, Miron PM, Pugh T, Quintero-Rivera F, Thurston VC, Wolff DJ, Zhao J, Fonseca R, Baughn LB. PMID: 40533444; PMCID: PMC12177088.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Telehealth and Time Burden in Patients With Advanced Cancer. JAMA Netw Open. 2025 Jun 02; 8(6):e2516769. Banerjee R, Acob YC. PMID: 40540276.
      View in: PubMed   Mentions:    Fields:    
    17. Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma. Blood Adv. 2025 May 13; 9(9):2336-2340. Banerjee R, Richards A, Midha S, Afrough A, Anwer F, Atanackovic D, Atrash S, Bachanova V, Beitinjaneh AM, Bhurtel E, Castaneda Puglianini O, Chhabra S, Cicero KI, Davis JA, Dhakal B, Dima D, Ferreri CJ, Forsberg PA, Freeman CL, Herr MM, Jain T, Janakiram M, Khouri J, Kocoglu MH, Kumar A, Liu Y, Locke F, McGuirk JP, Mikkilineni L, Nadeem O, Parrondo RD, Pasvolsky O, Peres LC, Purvey S, Raza S, Reshef R, Richard S, Rossi AC, Sborov DW, Shune L, Wagner CB, Zanwar SS, Sidana S, Patel KK, Hansen DK, Kumar SK, Lin Y, Martin TG, Voorhees PM, Anderson LD, Cowan AJ, Kaur G. PMID: 40088469; PMCID: PMC12127628.
      View in: PubMed   Mentions:    Fields:    
    18. Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium. Blood Cancer J. 2025 May 09; 15(1):92. Pasvolsky O, Dima D, Feng L, Dong W, Richards T, Davis JA, Afrough A, Vazquez-Martinez M, Sannareddy A, Goel U, Banerjee R, Khouri J, Cervoni F, Gaballa MR, Lieberman-Cribbin A, Rana MS, Julian K, Ferreri CJ, Shune L, DeJarnette S, Bhurtel E, Susanibar Adaniya S, Portuguese A, Hosoya H, Mikkilineni L, Kaur G, Rossi A, Herr MM, Schrum D, Lin C, Raza S, Lin Y, Midha S, Omar N, Atarsh S, McGuirk J, Sborov D, Voorhees P, Anwer F, Alsina M, Freeman C, Garfall AL, Razzo BM, Sidana S, Cowan AJ, Anderson LD, Hansen DK, Richard S, Patel KK, Lee HC, Grajales-Cruz A. PMID: 40346049; PMCID: PMC12064690.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Summarizing clinical evidence utilizing large language models for cancer treatments: a blinded comparative analysis. Front Digit Health. 2025; 7:1569554. Rubinstein S, Mohsin A, Banerjee R, Ma W, Mishra S, Kwok M, Yang P, Warner JL, Cowan AJ. PMID: 40364850; PMCID: PMC12069342.
      View in: PubMed   Mentions: 1  
    20. Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patients. Blood Cancer J. 2025 Apr 08; 15(1):61. Chunara F, Lugo C, Osinski K, Shah MR, Shah N, Kent J, Mohyuddin GR, Radhakrishnan SV, Kaur G, Chakraborty R, Banerjee R, Rasche L, Schinke C, D'Souza A, Szabo A, Mohan M. PMID: 40199861; PMCID: PMC11979001.
      View in: PubMed   Mentions: 1     Fields:    
    21. Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis. Blood Cancer J. 2025 Mar 28; 15(1):48. Dong S, Banerjee R, Khan AM, Wang M, Wang X, Afghahi A, Afrough A, Janakiram M, Wang B, Cowan AJ, Sperling AS, Anderson LD, Rajkumar SV, Kaur G. PMID: 40155649; PMCID: PMC11953251.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2025 Sep; 25(9):635-645. Chari A, Bal S, Ailawadhi S, Krishnan A, Patel KK, Berdeja JG, Garfall A, Callander N, Banerjee R, Alsina M, Nooka AK, Dhakal B, Gasparetto C, Costello C. PMID: 40175263.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702. Leukemia. 2025 Apr; 39(4):1001-1004. Banerjee R, Fritz AR, Akhtar OS, Freeman CL, Cowan AJ, Shah N, Landau HJ, Kumar SK, Vogl DT, Efebera YA, McCarthy PL, Vesole DH, Mendizabal A, Krishnan AY, Somlo G, Stadtmauer EA, Pasquini MC. PMID: 39994463; PMCID: PMC11978488.
      View in: PubMed   Mentions:    Fields:    
    24. Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy. Cancer Manag Res. 2025; 17:357-372. Goel U, Zanwar S, Cowan AJ, Banerjee R, Khouri J, Dima D. PMID: 39990276; PMCID: PMC11847446.
      View in: PubMed   Mentions:
    25. Development and validation of predictive models of early immune effector cell-associated hematotoxicity. Blood Adv. 2025 Feb 11; 9(3):606-616. Liang EC, Huang JJ, Portuguese AJ, Ortiz-Maldonado V, Albittar A, Wuliji N, Basom R, Jeon Y, Wu Q, Torkelson A, Kirchmeier D, Chutnik A, Pender B, Sorror M, Hill JA, Kopmar NE, Banerjee R, Cowan AJ, Green D, Gopal AK, Poh C, Shadman M, Hirayama AV, Till BG, Kimble EL, Iovino L, Chapuis AG, Otegbeye F, Cassaday RD, Milano F, Turtle CJ, Maloney DG, Gauthier J. PMID: 39626349; PMCID: PMC11847049.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Enhancing Multiple Myeloma Care: Implementation of Pharmacist-Led Prescribing of Immunomodulatory Drugs in an Academic Medical Setting. Clin Lymphoma Myeloma Leuk. 2025 Jun; 25(6):e424-e434. Indorf A, Kwok M, Jao M, Chen A, Baek GT, Banerjee R, Cicero KI, Cowan AJ, Portuguese AJ, Yoon L, Segal EM. PMID: 40016020.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma. Leukemia. 2025 Mar; 39(3):543-554. Costa LJ, Banerjee R, Mian H, Weisel K, Bal S, Derman BA, Htut MM, Nagarajan C, Rodriguez C, Richter J, Frigault MJ, Ye JC, van de Donk NWCJ, Voorhees PM, Puliafito B, Bahlis N, Popat R, Chng WJ, Ho PJ, Kaur G, Kapoor P, Du J, Schjesvold F, Berdeja J, Einsele H, Cohen AD, Mikhael J, Biru Y, Rajkumar SV, Lin Y, Martin TG, Chari A. PMID: 39870767; PMCID: PMC11879857.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    28. Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions. Diagnostics (Basel). 2025 Jan 18; 15(2). Cicero KI, Banerjee R, Kwok M, Dima D, Portuguese AJ, Chen D, Chalian M, Cowan AJ. PMID: 39857099; PMCID: PMC11765077.
      View in: PubMed   Mentions:
    29. Novel Treatment Options for Multiple Myeloma. JCO Oncol Pract. 2025 Jul; 21(7):950-961. Portuguese AJ, Banerjee R, Chen G, Reddi S, Cowan AJ. PMID: 39772633.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis. Blood. 2025 01 02; 145(1):75-84. Banerjee R, Sexton R, Cowan AJ, Rosenberg AS, Ailawadhi S, Rajkumar SV, Kumar S, Dispenzieri A, Lonial S, Durie BGM, Richardson PG, Usmani SZ, Hoering A, Orlowski RZ. PMID: 39321347.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting. JCO Oncol Pract. 2025 May; 21(5):596-598. Olivieri DJ, Banerjee R. PMID: 39705656.
      View in: PubMed   Mentions: 2     Fields:    
    32. Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma. Blood Cancer J. 2024 10 16; 14(1):180. Fortuna GG, Banerjee R, Savid-Frontera C, Song J, Morán-Segura CM, Nguyen JV, Lekakis L, Fernandez-Pol S, Samraj AN, Naresh KN, Vazquez-Martinez M, Baz RC, Spiegel JY, Mikkilineni L, Gubatan JM, Sidana S, de Menezes Silva Corraes A, Kalariya NM, Patel KK, Shim KG, Fonseca R, Ferreri C, Voorhees PM, Richard S, Valdes CR, Wolf JL, Cowan AJ, Sborov DW, Locke FL, Lin Y, Wang Y, Hansen DK. PMID: 39414769; PMCID: PMC11484697.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Smartwatch Biometrics in the Electronic Medical Record: Time for a New Vital Sign? JCO Clin Cancer Inform. 2024 Sep; 8:e2400161. Sankaran S, Banerjee R. PMID: 39348623.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel. Blood Cancer J. 2024 08 27; 14(1):149. Banerjee R, Biru Y, Cole CE, Faiman B, Midha S, Ailawadhi S. PMID: 39191731; PMCID: PMC11350150.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    35. Lithiophilic Dibenzamide Linkages to Impart Lithium Storage Capacity in Porous Polybenzamides. J Am Chem Soc. 2024 Jul 24; 146(29):20183-20192. Karak S, Singh H, Biswas A, Paul S, Manna S, Nishiyama Y, Pathak B, Banerjee A, Banerjee R. PMID: 39002137.
      View in: PubMed   Mentions:    Fields:    
    36. Thickness-Driven Synthesis and Applications of Covalent Organic Framework Nanosheets. Angew Chem Int Ed Engl. 2024 Jul 29; 63(31):e202406418. Koner K, Sasmal HS, Shetty D, Banerjee R. PMID: 38726702.
      View in: PubMed   Mentions: 4     Fields:    
    37. Porous Organic Nanotubes: Chemistry of One-Dimensional Space. Acc Chem Res. 2024 Jul 02; 57(13):1839-1850. Dey K, Koner K, Mukhopadhyay RD, Shetty D, Banerjee R. PMID: 38886130.
      View in: PubMed   Mentions: 1     Fields:    
    38. Dramatically elevated plasma vascular endothelial growth factor levels from influenza A infection in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome: A case report. EJHaem. 2024 Aug; 5(4):842-844. Kannan A, Zhuo Y, Banerjee R. PMID: 39157604; PMCID: PMC11327705.
      View in: PubMed   Mentions:
    39. Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization. Transplant Cell Ther. 2024 08; 30(8):774.e1-774.e12. Portuguese AJ, Yeh AC, Banerjee R, Holmberg L, Wuliji N, Green DJ, Mielcarek M, Gopal AK, Gooley T, Stevenson P, Cowan AJ. PMID: 38768908; PMCID: PMC11296896.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. TACTUM: Trends in Access to Cellular Therapies in Multiple Myeloma, Perspectives of Treating Versus Referring Physicians. Transplant Cell Ther. 2024 09; 30(9):925.e1-925.e6. Atallah R, Ahmed N, Ayoobkhan F, Saif MSI, Logan E, Shrestha A, Anwer F, Mahmoudjafari Z, Mushtaq MU, Hashmi H, Ganguly S, McGuirk J, Shebli A, Abdallah AO, Banerjee R, Alkharabsheh O. PMID: 38763416.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. How can we stamp out high-risk myeloma? Blood. 2024 05 16; 143(20):2015-2016. Banerjee R, Mikhael JR. PMID: 38753353.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Mitigating time toxicity in lymphoma and multiple myeloma. Leuk Lymphoma. 2024 Oct; 65(10):1418-1429. Di M, Su CT, Cowan AJ, Gopal AK, Banerjee R. PMID: 38749027.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma. Blood Adv. 2024 05 14; 8(9):2207-2216. Reyes KR, Liu YC, Huang CY, Banerjee R, Martin T, Wong SW, Wolf JL, Arora S, Shah N, Chari A, Chung A. PMID: 38429087; PMCID: PMC11061209.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    44. Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis. Blood Cancer J. 2024 03 22; 14(1):52. Hoff FW, Banerjee R, Khan AM, McCaughan G, Wang B, Wang X, Roose J, Anderson LD, Cowan AJ, Rajkumar SV, Kaur G. PMID: 38519476; PMCID: PMC10959949.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic. Blood Adv. 2024 02 27; 8(4):895-898. Banerjee R, Poh C, Hirayama AV, Gauthier J, Cassaday RD, Shadman M, Cowan AJ, Till BG, Green DJ, Kiem HP, Gopal AK, Maloney DG. PMID: 38197942; PMCID: PMC10875255.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    46. Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2024 Jul; 24(7):446-454.e3. Banerjee R, Cowan AJ, Ortega M, Missimer C, Carpenter PA, Oshima MU, Salit RB, Vo PT, Lee CJ, Mehta RS, Kuderer NM, Shankaran V, Lee SJ, Su CT. PMID: 38521640; PMCID: PMC11189752.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    47. Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation. Br J Haematol. 2024 03; 204(3):887-891. Hammons L, Haider S, Portuguese AJ, Banerjee R, Szabo A, Pasquini M, Chhabra S, Radhakrishnan S, Mohan M, Narra R, Dong J, Janz S, Shah NN, Hamadani M, D'Souza A, Hari P, Dhakal B. PMID: 38054558.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Opportunity Strikes for Reducing Cancer Drug Waste: Bortezomib as an Example of Vial Mis-Sizing in Oncology. JCO Oncol Pract. 2024 02; 20(2):165-168. Abrams HR, Chen AW, Banerjee R. PMID: 37956392.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians. Blood Cancer J. 2023 11 06; 13(1):162. Banerjee R, Wang B, Anderson LD, McCaughan G, Mehra N, Cowan AJ, Rajkumar SV, Kaur G. PMID: 37926718; PMCID: PMC10625982.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. Association between dexamethasone exposure and visually significant cataracts in multiple myeloma. Am J Hematol. 2024 01; 99(1):E12-E14. Banerjee R, Hurtado Martínez JA, Flores Pérez PA, Porras N, Hydren J, Ahlstrom JM, Taravati P, Cowan AJ. PMID: 37853832.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    51. Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling. Front Oncol. 2023; 13:1240966. Banerjee R, Cicero KI, Lee SS, Cowan AJ. PMID: 37849816; PMCID: PMC10577204.
      View in: PubMed   Mentions: 9  
    52. Randomized phase 2 study of digital life coaching during transplantation for myeloma. Bone Marrow Transplant. 2023 12; 58(12):1406-1409. Banerjee R, Huang CY, Ryan C, Lee A, Brassil KJ, Moore J, Arora S, Chung A, Wong SW, Wolf J, Martin T, Dhruva A, Shah N. PMID: 37743374.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    53. Nuclear Resonance Vibrational Spectroscopy Definition of Peroxy Intermediates in Catechol Dioxygenases: Factors that Determine Extra- versus Intradiol Cleavage. J Am Chem Soc. 2023 07 19; 145(28):15230-15250. Babicz JT, Rogers MS, DeWeese DE, Sutherlin KD, Banerjee R, Böttger LH, Yoda Y, Nagasawa N, Saito M, Kitao S, Kurokuzu M, Kobayashi Y, Tamasaku K, Seto M, Lipscomb JD, Solomon EI. PMID: 37414058; PMCID: PMC10804917.
      View in: PubMed   Mentions: 2     Fields:    
    54. Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis. Blood Adv. 2023 06 27; 7(12):2746-2757. Ragon BK, Shah MV, D'Souza A, Estrada-Merly N, Gowda L, George G, de Lima M, Hashmi S, Kharfan-Dabaja MA, Majhail NS, Banerjee R, Saad A, Hildebrandt GC, Mian H, Abid MB, Battiwalla M, Lekakis LJ, Patel SS, Murthy HS, Nieto Y, Strouse C, Badawy SM, Al Hadidi S, Dholaria B, Aljurf M, Vesole DH, Lee CH, Pawarode A, Gergis U, Miller KC, Holmberg LA, Afrough A, Solh M, Munshi PN, Nishihori T, Anderson LD, Wirk B, Kaur G, Qazilbash MH, Shah N, Kumar SK, Usmani SZ. PMID: 36827681; PMCID: PMC10275699.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    55. Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy. Eur J Nucl Med Mol Imaging. 2023 09; 50(11):3349-3353. Banerjee R, Wang V, Huang CY, Pandita D, Leonard MK, LaRue S, Ahmadi M, Kaplan L, Ai WZ, Fakhri B, Spinner M, Seshadri MR, Pampaloni MH, Andreadis CB. PMID: 37300573; PMCID: PMC10853015.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma. Blood Cancer J. 2023 05 30; 13(1):89. Banerjee R, Williams L, Mikhael JR. PMID: 37248225; PMCID: PMC10226974.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in Myeloma. Transplant Cell Ther. 2023 08; 29(8):504.e1-504.e7. Zafar A, Huang CY, Lo M, Arora S, Chung A, Wong SW, Wolf J, Martin TG, Shah N, Banerjee R. PMID: 37244643.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    58. Reproducibility of Femoropopliteal Artery Intravascular Ultrasound Imaging in Patients With Peripheral Artery Disease. Am J Cardiol. 2023 07 15; 199:1-6. Soney H, Kakkilaya A, Vazquez DF, Banerjee R, Rosol Z, Tsai S, Banerjee S. PMID: 37210800.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. Role of Lipoprotein A in Lower Extremity Peripheral Artery Disease. Am J Cardiol. 2023 07 01; 198:47-49. Banerjee R, Weideman S, Fernandez-Vazquez D, Banerjee A, Hasan A, Tsai S. PMID: 37201230.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Significance of the pee-value: relevance of 24-hour urine studies for patients with myeloma. Leuk Lymphoma. 2023 06; 64(6):1186-1193. Natsuhara KH, Huang CY, Knoche J, Arora S, Chung A, Martin T, Wolf J, Wong SW, Shah N, Banerjee R. PMID: 37096638.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Professional Challenges for United States Hematology/Oncology Trainees during COVID-19. Cancer Invest. 2023 Jul; 41(6):539-547. Banerjee R, Kareff SA, Leyfman Y, Dhawan N, Hammons LR, Desai A, Tsang M, Velazquez AI, Nizam A. PMID: 37017426.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    62. Demographics, Motivations, and Experiences of Participants in Transplantation or Cellular Therapy Fellowships. Transplant Cell Ther. 2023 06; 29(6):394.e1-394.e7. Banerjee R, Kelkar AH, Durani U, Anagnostou T, Nishitani M, Mallhi K, Majhail NS, Logan AC. PMID: 36934994.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma. Transplant Cell Ther. 2023 06; 29(6):350-355. Reyes KR, Huang CY, Lo M, Arora S, Chung A, Wong SW, Wolf J, Olin RL, Martin T, Shah N, Banerjee R. PMID: 36933659.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    64. Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study. Br J Haematol. 2023 06; 201(5):935-939. Ge AY, Huang CY, Banerjee R, Knoche J, Chung A, Arora S, Martin TG, Wolf J, Wong SW, Wiita AP, Shah N. PMID: 36846905.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    65. Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium. J Clin Oncol. 2023 05 10; 41(14):2594-2606. Wang Y, Jain P, Locke FL, Maurer MJ, Frank MJ, Munoz JL, Dahiya S, Beitinjaneh AM, Jacobs MT, Mcguirk JP, Vose JM, Goy A, Andreadis C, Hill BT, Dorritie KA, Oluwole OO, Deol A, Paludo J, Shah B, Wang T, Banerjee R, Miklos DB, Rapoport AP, Lekakis L, Ghobadi A, Neelapu SS, Lin Y, Wang ML, Jain MD. PMID: 36753699; PMCID: PMC10489553.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    66. Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma. J Oncol Pharm Pract. 2023 Oct; 29(7):1715-1724. Rath C, Yoo C, Cheplowitz H, Lo M, Young R, Guglielmo J, Saunders IM, Banerjee R, Young R, Kumar A, Chung A, Rosenberg AS, Costello C, Fine J, Wilson M, Patel N, Banez MT. PMID: 36731514.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. Clinical Validation of a Continuous Monitoring Mobile Cardiac Detection Device for Atrial Fibrillation. Am J Cardiol. 2023 02 15; 189:61-63. Banerjee S, Das T, Grodin J, Minniefield N, Tsai S, Banerjee R, Persen K, Novak S. PMID: 36508764.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Innovation in BCMA CAR-T therapy: Building beyond the Model T. Front Oncol. 2022; 12:1070353. Banerjee R, Lee SS, Cowan AJ. PMID: 36505779; PMCID: PMC9729952.
      View in: PubMed   Mentions: 7  
    69. Myeloma, melphalan, and the taste of transplantation. Cancer. 2022 11 01; 128(21):3784-3786. Banerjee R. PMID: 36041229.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    70. Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma. Blood Adv. 2022 07 12; 6(13):3991-3995. Kansagra A, Dispenzieri A, Fraser R, Estrada-Merly N, Sidana S, Nishihori T, Hansen DK, Anderson LD, Banerjee R, Bumma N, Dhakal B, Khouri J, Landau H, Lee C, Mian H, Nathan S, Savani B, Kumar S, Qazilbash M, Shah N, D'Souza A. PMID: 35507742; PMCID: PMC9278304.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    71. SNPs and PROs in myeloma: the most ambitious crossover of all time? Bone Marrow Transplant. 2022 10; 57(10):1475-1476. Banerjee R, Shah N. PMID: 35768572.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report. EJHaem. 2022 Aug; 3(3):1000-1002. Goyal V, Salmasi G, Leavitt AD, Rubenstein JL, Banerjee R. PMID: 36051043; PMCID: PMC9421997.
      View in: PubMed   Mentions: 2  
    73. Severe electrolyte derangements from lysozymuria in acute myeloid leukemia. EJHaem. 2022 Aug; 3(3):1018-1020. Pérez-Pinzón J, Olin RL, Banerjee R. PMID: 36051078; PMCID: PMC9421957.
      View in: PubMed   Mentions: 2  
    74. Financial toxicity in hematological malignancies: a systematic review. Blood Cancer J. 2022 04 22; 12(4):74. Ouchveridze E, Banerjee R, Desai A, Aziz M, Lee-Smith W, Mian H, Berger K, McClune B, Sborov D, Qazilbash M, Kumar S, Mohyuddin GR. PMID: 35459862; PMCID: PMC9033803.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    75. Peptide mediated, enhanced toxicity of a bacterial pesticidal protein against southern green stink bug. Microb Biotechnol. 2022 07; 15(7):2071-2082. Banerjee R, Flores-Escobar B, Chougule NP, Cantón PE, Dumitru R, Bonning BC. PMID: 35315236; PMCID: PMC9249324.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    76. Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study. JMIR Form Res. 2022 Mar 04; 6(3):e33701. Banerjee R, Huang CY, Dunn L, Knoche J, Ryan C, Brassil K, Jackson L, Patel D, Lo M, Arora S, Wong SW, Wolf J, Martin Iii T, Dhruva A, Shah N. PMID: 35039279; PMCID: PMC8933800.
      View in: PubMed   Mentions: 4     Fields:    
    77. Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: A case report. J Oncol Pharm Pract. 2022 Jul; 28(5):1244-1248. Vo K, Guan T, Banerjee R, Lo M, Young R, Shah N. PMID: 35084252.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    78. Anthracyclines in a patient with acute leukemia and severe cardiomyopathy requiring mechanical support: A case report. J Oncol Pharm Pract. 2022 Apr; 28(3):729-732. Banerjee R, Lo M, Klein L, Aras M, Logan AC. PMID: 34846217.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients. Bone Marrow Transplant. 2022 02; 57(2):295-298. Tan CR, Estrada-Merly N, Landau H, Lekakis L, Banerjee R, Mian H, Usmani SZ, Hanbali A, Lazarus HM, Kyle RA, Dholaria B, Bal S, Strouse C, Murthy HS, Wirk B, Nishihori T, Kumar S, Shah N, Qazilbash M, D'Souza A. PMID: 34802047; PMCID: PMC8825695.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. Transplant Cell Ther. 2022 02; 28(2):83.e1-83.e9. Sidana S, Kumar S, Fraser R, Estrada-Merly N, Giralt S, Agrawal V, Anderson LD, Aljurf M, Banerjee R, Bashey A, Battiwalla M, Beitinjaneh A, Chakraborty R, Chhabra S, Dhakal B, Dholaria B, Hashmi S, Janakiram M, Lee C, Lekakis L, Murthy HS, Parrondo R, Wangjam T, Usmani S, Shah N, Qazilbash M, D'Souza A. PMID: 34781066; PMCID: PMC8900987.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    81. Synthetic control arms in studies of multiple myeloma and diffuse large B-cell lymphoma. Br J Haematol. 2022 03; 196(5):1274-1277. Banerjee R, Midha S, Kelkar AH, Goodman A, Prasad V, Mohyuddin GR. PMID: 34750805.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    82. Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplant. 2022 01; 57(1):31-37. Pasvolsky O, Yeshurun M, Fraser R, Estrada-Merly N, Rozovski U, Shargian-Alon L, Assal A, Banerjee R, Bumma N, Gale RP, Hagen P, Holmberg L, Hossain NM, Lazarus HM, Lee C, Mian H, Miller KC, Nathan S, Nagler A, Nishihori T, Parrondo RD, Patel S, Schroeder MA, Usmani SZ, Wang T, Wirk B, Kumar S, Shah N, Qazilbash MH, D'Souza A. PMID: 34608275; PMCID: PMC8764606.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    83. Nuclear Resonance Vibrational Spectroscopic Definition of the Fe(IV)2 Intermediate Q in Methane Monooxygenase and Its Reactivity. J Am Chem Soc. 2021 10 06; 143(39):16007-16029. Jacobs AB, Banerjee R, Deweese DE, Braun A, Babicz JT, Gee LB, Sutherlin KD, Böttger LH, Yoda Y, Saito M, Kitao S, Kobayashi Y, Seto M, Tamasaku K, Lipscomb JD, Park K, Solomon EI. PMID: 34570980; PMCID: PMC8631202.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    84. Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma. Future Oncol. 2021 Dec; 17(35):4849-4860. Banerjee R, Lo M, Martin TG. PMID: 34553603.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Lack of equipoise in the LIGHTHOUSE trial for patients with relapsed multiple myeloma: An ethical concern. Eur J Cancer. 2021 11; 157:533-535. Mohyuddin GR, Banerjee R, Goodman AM. PMID: 34544634.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    86. Rethinking mechanisms of neurotoxicity with BCMA directed therapy. Crit Rev Oncol Hematol. 2021 Oct; 166:103453. Mohyuddin GR, Banerjee R, Alam Z, Berger KE, Chakraborty R. PMID: 34461271.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    87. Characteristics of Registered Studies of Chimeric Antigen Receptor Therapies: A Systematic Review. JAMA Netw Open. 2021 07 01; 4(7):e2115668. Banerjee R, Prasad V. PMID: 34236412; PMCID: PMC8267610.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    88. Toci or not toci: innovations in the diagnosis, prevention, and early management of cytokine release syndrome. Leuk Lymphoma. 2021 11; 62(11):2600-2611. Banerjee R, Fakhri B, Shah N. PMID: 34151714.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    89. Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health. JCO Clin Cancer Inform. 2021 06; 5:668-678. Banerjee R, Shah N, Dicker AP. PMID: 34110929.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    90. The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond. Curr Hematol Malig Rep. 2021 04; 16(2):132-139. Banerjee R, Kelkar AH, Logan AC, Majhail NS, Pemmaraju N. PMID: 33788125; PMCID: PMC8011363.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. Whole genome comparisons reveal panmixia among fall armyworm (Spodoptera frugiperda) from diverse locations. BMC Genomics. 2021 Mar 12; 22(1):179. Schlum KA, Lamour K, de Bortoli CP, Banerjee R, Meagher R, Pereira E, Murua MG, Sword GA, Tessnow AE, Viteri Dillon D, Linares Ramirez AM, Akutse KS, Schmidt-Jeffris R, Huang F, Reisig D, Emrich SJ, Jurat-Fuentes JL. PMID: 33711916; PMCID: PMC7953542.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    92. Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma. Transplant Cell Ther. 2021 06; 27(6):477.e1-477.e7. Banerjee R, Marsal J, Huang CY, Lo M, Thiruvengadam SK, Kennedy VE, Arora S, Wolf JL, Martin TG, Wong SW, Shah N. PMID: 33831353.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    93. Maximizing Home Time for Persons With Cancer. JCO Oncol Pract. 2021 09; 17(9):513-516. Banerjee R, George M, Gupta A. PMID: 33661703.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    94. Driving distances and loss to follow-up after hematopoietic cell transplantation. EJHaem. 2021 May; 2(2):272-275. Banerjee R, Loren AW. PMID: 35845266; PMCID: PMC9175729.
      View in: PubMed   Mentions: 3  
    95. When and How to Treat Relapsed Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:358-375. Nathwani N, Bertamini L, Banerjee R, Gay F, Shah N, Krishnan A. PMID: 34010043.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    96. Streamlined phage display library protocols for identification of insect gut binding peptides highlight peptide specificity. Curr Res Insect Sci. 2021; 1:100012. Mishra R, Guo Y, Kumar P, Cantón PE, Tavares CS, Banerjee R, Kuwar S, Bonning BC. PMID: 36003592; PMCID: PMC9387513.
      View in: PubMed   Mentions: 5  
    97. 'Stat' workflow modifications to expedite care after needlestick injuries. Occup Med (Lond). 2021 02 06; 71(1):20-24. Smith JL, Banerjee R, Linkin DR, Schwab EP, Saberi P, Lanzi M. PMID: 33399827.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    98. Benzodiazepine and zolpidem prescriptions during autologous stem cell transplantation. EJHaem. 2021 May; 2(2):276-279. Banerjee R, Lazar AA, Dunn L, Knoche J, Lo M, Arora S, Wong SW, Wolf JL, Martin TG, Dhruva A, Shah N. PMID: 35845271; PMCID: PMC9175938.
      View in: PubMed   Mentions: 4  
    99. Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19. Nat Rev Clin Oncol. 2021 01; 18(1):7-8. Banerjee R, Prasad V. PMID: 33139895; PMCID: PMC7604917.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    100. Virtual Conferences: Optimizing Oncology Nurses' Experience. Clin J Oncol Nurs. 2020 12 01; 24(6):699-702. Brassil KJ, Banerjee R. PMID: 33216062.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    101. Partial warfarin reversal prior to hip fracture surgical intervention in geriatric trauma patients effects on blood loss and transfusions. J Clin Orthop Trauma. 2021 Mar; 14:45-51. Meinig R, Cornutt D, Jarvis S, Salottolo K, Kelly M, Harrison P, Nentwig M, Morgan S, Nwafo N, McNair P, Banerjee R, Woods B, Bar-Or D. PMID: 33717896; PMCID: PMC7920139.
      View in: PubMed   Mentions: 1  
    102. Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors. Biol Blood Marrow Transplant. 2020 11; 26(11):2132-2138. Banerjee R, Yi JC, Majhail NS, Jim HSL, Uberti J, Whalen V, Loren AW, Syrjala KL. PMID: 32781287; PMCID: PMC7414780.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    103. High-Resolution XFEL Structure of the Soluble Methane Monooxygenase Hydroxylase Complex with its Regulatory Component at Ambient Temperature in Two Oxidation States. J Am Chem Soc. 2020 08 19; 142(33):14249-14266. Srinivas V, Banerjee R, Lebrette H, Jones JC, Aurelius O, Kim IS, Pham CC, Gul S, Sutherlin KD, Bhowmick A, John J, Bozkurt E, Fransson T, Aller P, Butryn A, Bogacz I, Simon P, Keable S, Britz A, Tono K, Kim KS, Park SY, Lee SJ, Park J, Alonso-Mori R, Fuller FD, Batyuk A, Brewster AS, Bergmann U, Sauter NK, Orville AM, Yachandra VK, Yano J, Lipscomb JD, Kern J, Högbom M. PMID: 32683863; PMCID: PMC7457426.
      View in: PubMed   Mentions: 34     Fields:    Translation:Cells
    104. Are Observational, Real-World Studies Suitable to Make Cancer Treatment Recommendations? JAMA Netw Open. 2020 07 01; 3(7):e2012119. Banerjee R, Prasad V. PMID: 32729916.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    105. Is anticoagulation reversal necessary prior to surgical treatment of geriatric hip fractures? J Clin Orthop Trauma. 2020 Feb; 11(Suppl 1):S93-S99. Meinig R, Jarvis S, Orlando A, Nwafo N, Banerjee R, McNair P, Woods B, Harrison P, Nentwig M, Kelly M, Smith W, Bar-Or D. PMID: 31992926; PMCID: PMC6977537.
      View in: PubMed   Mentions: 12  
    106. Molecular mechanisms of human P2X3 receptor channel activation and modulation by divalent cation bound ATP. Elife. 2019 06 24; 8. Li M, Wang Y, Banerjee R, Marinelli F, Silberberg S, Faraldo-Gómez JD, Hattori M, Swartz KJ. PMID: 31232692; PMCID: PMC6590987.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    107. Profanities, Promises, and Hospices. J Clin Oncol. 2019 07 01; 37(19):1677-1678. Banerjee R. PMID: 31026213.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    108. Charting a course for chemistry. Nat Chem. 2019 Apr; 11(4):286-294. Aspuru-Guzik A, Baik MH, Balasubramanian S, Banerjee R, Bart S, Borduas-Dedekind N, Chang S, Chen P, Corminboeuf C, Coudert FX, Cronin L, Crudden C, Cuk T, Doyle AG, Fan C, Feng X, Freedman D, Furukawa S, Ghosh S, Glorius F, Jeffries-El M, Katsonis N, Li A, Linse SS, Marchesan S, Maulide N, Milo A, Narayan ARH, Naumov P, Nevado C, Nyokong T, Palacin R, Reid M, Robinson C, Robinson G, Sarpong R, Schindler C, Schlau-Cohen GS, Schmidt TW, Sessoli R, Shao-Horn Y, Sleiman H, Sutherland J, Taylor A, Tezcan A, Tortosa M, Walsh A, Watson AJB, Weckhuysen BM, Weiss E, Wilson D, Yam VW, Yang X, Ying JY, Yoon T, You SL, Zarbin AJG, Zhang H. PMID: 30903035.
      View in: PubMed   Mentions: 3     Fields:    
    109. Postdischarge Emergency Department Visits: Good, Bad, or Ugly? J Hosp Med. 2018 Sep; 13(9):646-647. Banerjee R, Greysen SR. PMID: 29538470.
      View in: PubMed   Mentions: 1     Fields:    
    110. Bilobal architecture is a requirement for calmodulin signaling to CaV1.3 channels. Proc Natl Acad Sci U S A. 2018 03 27; 115(13):E3026-E3035. Banerjee R, Yoder JB, Yue DT, Amzel LM, Tomaselli GF, Gabelli SB, Ben-Johny M. PMID: 29531055; PMCID: PMC5879666.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    111. Late effects of blood and marrow transplantation. Haematologica. 2017 11; 102(11):e465. Banerjee R, Luskin MR, Loren AW. PMID: 29079647; PMCID: PMC5664410.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    112. Mechanism and DNA-based detection of field-evolved resistance to transgenic Bt corn in fall armyworm (Spodoptera frugiperda). Sci Rep. 2017 09 07; 7(1):10877. Banerjee R, Hasler J, Meagher R, Nagoshi R, Hietala L, Huang F, Narva K, Jurat-Fuentes JL. PMID: 28883440; PMCID: PMC5589895.
      View in: PubMed   Mentions: 67     Fields:    Translation:Animals
    113. If You Book It, Will They Come? Attendance at Postdischarge Follow-Up Visits Scheduled by Inpatient Providers. J Hosp Med. 2017 08; 12(8):618-625. Banerjee R, Suarez A, Kier M, Honeywell S, Feng W, Mitra N, Grande D, Myers J. PMID: 28786427.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    114. Comparative molecular analyses of invasive fall armyworm in Togo reveal strong similarities to populations from the eastern United States and the Greater Antilles. PLoS One. 2017; 12(7):e0181982. Nagoshi RN, Koffi D, Agboka K, Tounou KA, Banerjee R, Jurat-Fuentes JL, Meagher RL. PMID: 28738081; PMCID: PMC5524310.
      View in: PubMed   Mentions: 41     Fields:    Translation:AnimalsCells
    115. Resilience Through Grieving Rounds. Acad Med. 2017 Jul; 92(7):900. Banerjee R. PMID: 28654521.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study. Br J Haematol. 2018 04; 181(2):259-261. Mato AR, Timlin C, Ujjani C, Skarbnik A, Howlett C, Banerjee R, Nabhan C, Schuster SJ. PMID: 28220935.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    117. Illiteracy. The Pharos of Alpha Omega Alpha Honor Medical Society. 2017; 80(1):65. Banerjee R.
    118. Coloring the Silence. Acad Med. 2016 08; 91(8):1088. Banerjee R. PMID: 27465091.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies. Curr Hematol Malig Rep. 2015 Sep; 10(3):225-36. Luskin MR, Banerjee R, Del Percio S, Loren AW. PMID: 26162948.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    120. A rendezvous with the queen of ion channels: Three decades of ion channel research by David T Yue and his Calcium Signals Laboratory. Channels (Austin). 2016; 10(1):20-32. Dick IE, Limpitikul WB, Niu J, Banerjee R, Issa JB, Ben-Johny M, Adams PJ, Kang PW, Lee SR, Sang L, Yang W, Babich J, Zhang M, Bazazzi H, Yue NC, Tomaselli GF. PMID: 26176690; PMCID: PMC4802785.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    121. Occurrence and recall rates of fertility discussions with young breast cancer patients. Support Care Cancer. 2016 Jan; 24(1):163-171. Banerjee R, Tsiapali E. PMID: 25967235.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    122. Chemical sensing in two dimensional porous covalent organic nanosheets. Chem Sci. 2015 Jul 01; 6(7):3931-3939. Das G, Biswal BP, Kandambeth S, Venkatesh V, Kaur G, Addicoat M, Heine T, Verma S, Banerjee R. PMID: 29218164; PMCID: PMC5707461.
      View in: PubMed   Mentions: 70  
    123. Distraction subtalar arthrodesis. Foot Ankle Clin. 2015 Jun; 20(2):335-51. Jackson JB, Jacobson L, Banerjee R, Nickisch F. PMID: 26043248.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    124. Medical student awareness of and interest in clinical informatics. J Am Med Inform Assoc. 2015 Apr; 22(e1):e42-7. Banerjee R, George P, Priebe C, Alper E. PMID: 25726567; PMCID: PMC7659213.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    125. To comfort, always. J Palliat Med. 2014 Mar; 17(3):365-6. Banerjee R. PMID: 24548284.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    126. The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid. J Virol. 2014 Jan; 88(2):948-60. Zins SR, Nelson CD, Maginnis MS, Banerjee R, O'Hara BA, Atwood WJ. PMID: 24198413; PMCID: PMC3911681.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    127. Lyme neuroborreliosis presenting with alexithymia and suicide attempts. J Clin Psychiatry. 2013 Oct; 74(10):981. Banerjee R, Liu JJ, Minhas HM. PMID: 24229748.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    128. Unique susceptibility of a human lung carcinoid tumor cell line to infection with BK virus. Virus Res. 2010 Apr; 149(1):128-32. Haley SA, O'Hara BA, Banerjee R, Atwood WJ. PMID: 20122973.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    Rahul's Networks
    Concepts (336)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (29)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.